NEWS

Oct 19

Function Therapeutics receives SBIR award to study potential treatment for liver disease (MASH)

Function Therapeutics has been awarded a Phase 1 Small Business Innovation Research (SBIR) grant from the National Institute of Diabetes...

Oct 19

Parmodulin shows beneficial effects in obese mice

In the Journal of Thrombosis and Haemostasis, the lab of Dr. James Luyendyk (Michigan State University) and colleagues reported the...

Jun 4

Function Therapeutics receives SBIR award to study acute kidney injury (AKI)

Function Therapeutics has been awarded a Phase 1 Small Business Innovation Research (SBIR) grant from the National Institute of Diabetes...